Multicompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1
|
|
- Jemimah Knight
- 6 years ago
- Views:
Transcription
1 Multicompartment Pharmacokinetic Models Objectives To draw schemes and write differential equations for multicompartment models To recognize and use integrated equations to calculate dosage regimens To determine parameter values using the method of residuals To calculate various V values To use the non-compartmental method of parameter estimation Multicompartment Models Rapid equilibration assumption not always true Distribution may take some finite time Body may be represented by two equilibrated compartments with distribution between the two Semi-log figure will show a distribution phase Chapter 30
2 Linear Plot One Compartment Model Dose = 0 mg; V = 2.5 L; kel = 0.5 hr - Cp = Cp 0 e -kel t One Compartment Model Semi-log Plot Cp = Cp 0 e -kel t Dose = 0 mg; V = 2.5 L; kel = 0.5 hr Drug Disposition Distribution Commonly observed when early data are collected Deviation from a single exponential line A rapid drop followed by a slower terminal phase Body can be represented by two (or more) compartments Chapter 30 2
3 Semi-log Plot Two Compartment 0 first phase second phase 0. Cp = 24 e -.5 t + 6 e t Two Compartments Central compartment rapidly perfused tissues Peripheral compartment slowly perfused tissues Scheme Two Compartment Blood Kidney Liver X Central k2 k2 kel X 2 Peripheral Fat Bone Chapter 30 3
4 Two Compartment Differential Equations Central Compartment dx = kel X dt k2 X + k2 X 2 Peripheral Compartment dx 2 dt = k2 X k2 X 2 The Differential Equations dx = k2 X dt 2 k2 X kel X dx 2 = k2 X dt k2 X 2 Take Laplace of the Equations s X X (0) = k2 X2 k2 X kel X s X2 X 2 (0) = k2 X k2 X2 Since X (0) = Dose and X 2 (0) = 0 X2 = k2 X (s + k2) Chapter 30 4
5 Substitute and Rearrange s X Dose = k2 k2 X (k2 + kel) X (s + k2) s X+(k2 + kel) X k2 k2 X = Dose (s + k2) X [ s (s + k2) + (k2 + kel) (s + k2) k2 k2] = Dose (s + k2) X [s 2 + s (k2+ k2 + kel) + k2 kel] = Dose (s + k2) Notice the similarity with [s 2 + s (α+β)+α β]=(s +α) (s +β) Getting close now If and (α + β) = k2 + k2 + kel α β= k2 kel X [s 2 + s (α+β)+α β]= Dose (s + k2) X (s +α) (s +β)= Dose (s + k2) Dose (s + k2) X = (s +α) (s +β) Back Transforming X = Dose (s+ k2) (s +α) (s +β) The denominator has a power of 2 in s and no repeat terms. Note the numerator has a power of in s Considering the denominator: (s + α) (s + β) = 0 Roots or solutions are -α and -β Chapter 30 5
6 First root is -α Root Dose (s+ k2) X = (s +α) (s +β) Dose (s+ k2) (s +α) (s+β) Dose (k2 α) e ( β α) α t Root 2 Dose (s+ k2) X = (s +α) (s +β) Second root is -β Dose (s+ k2) (s +α) (s+β) Dose (k2 β) α β ( ) e β t Putting It Together Dose (α k2) e ( α β) α t Dose (α k2) e ( α β) α t + OR Cp = A e -α t + B e -β t where Dose (k2 β) e ( β t α β) Dose (k2 β) e ( β t α β) and Dose (α k2) A = V (α β) B= Dose (k2 β) V (α β) Chapter 30 6
7 Integrated Equation α+β= kel + k2 + k2 α β= kel k2 Cp = A e -α t + B e -β t ( α,β= α+β )± ( α+β )2 4 α β 2 or ( kel + k2 + k2) ± kel + k2 + k2 α,β= ( )2 4 kel k2 2 Parameter Determination Method of Residuals Parameters A, B, α and β can be determined using the method of residuals Since α > β (if α/β > 5) e -α t approaches 0 quickly Terminal data points will be on a line Method of Residuals Cp late = B e -β t Plotted on semi-log graph paper should give a straight line Calculate β from the terminal slope Chapter 30 7
8 Terminal Slope 0 slope > β 0. Cp = 24 e -.5 t + 6 e t Terminal Half-life t /2 = ln(2)/β Biological or terminal half-life [= equivalent to ln(2)/kel with one compartment model] Residual Residual = Cp - Cp late = A e -α t 0 0. α > β slope -> α Chapter 30 8
9 Now Calculate k2, kel, k2 A β+ B α k2 = A +B kel = α β k2 k2 =α+β k2 kel Effect of k2 and k2 Ratio k2/k2 = /4 9 k2/k2 = /2 8 k2/k2 = / 7 k2/k2 = 2/ 6 k2/k2 = 4/ Time (hour) Effect of k2 and k2 Ratio Effect of k2/k2 ratio The higher the ratio greater the distribution into the peripheral compartment At the extremes low ratio - less distribution into second compartment high ratio and no early data - looks like one compartment model Chapter 30 9
10 Magnitude of k2 and k2 k2/k2 = 0.5/ k2/k2 = /0.5 8 k2/k2 = 2/ 7 k2/k2 = 4/2 6 k2/k2 = 8/4 5 k2/2 = 6/ Time (hour) Magnitude of k2 and k2 Larger values approach one compartment assumption Volume of Distribution V V Apparent volume of central compartment ( ) V = Dose A + B = Dose 0 since A+B=Cp0 Cp Use to calculate Cp 0 after an IV bolus administration Chapter 30
11 Volume of Distribution V area (= V β ) V area V area = Dose β AUC = V kel β = Clearance β Useful for dosing calculations, easy to calculate from Dose and AUC Volume of Distribution V extrap V extrap Volume extrapolated V extrap = Dose B Ignores distribution phase Volume of Distribution V ss V ss Steady state volume V ss = V k2 + k2 k2 Relates total amount in the body (at steady state) with drug concentrations in plasma or blood Chapter 30
12 Steady State Volume 0 X X Volumes of Distribution V extrap > V area > V ss > V Example Calculation Time (hr) Cp (mg/l) Cp late (mg/l) Residual (mg/l) I.V. Bolus 500 mg Chapter 30 2
13 The Plots 0 Cp Residual Calculations B = mg/l, β = (ln - ln 0.5)/2 = 2.996/2 = 0.25 hr - A = 25 mg/l, α = (ln 25 - ln 0.27)/3 = 4.528/3 =.5 hr - Cp = 25 e -.5 x t + e x t Microconstants k2 = kel = α β k2 A β+ B α = A +B = 0.6 hr = = 0.62 hr k2 =α+β k2 kel = = 0.53 hr - Chapter 30 3
14 Volumes of Distribution V = Dose A + B = = 4.3 L V area = Dose β AUC = = 34.3 L V extrap = Dose B = 500 = 50 L V ss = V k2 + k = 4.3 = 26.7 L k2 0.6 Note:V extrap > V area > V ss > V [50 > 34.3 > 26.7 > 4.3] AUC = = 58.3 mg.hr.l - Dosage Calculations Initial Concentration, Cp 0 V = Dose Cp 0 0 Dose = V Cp required To achieve a Cp 0 of 20 mg/l give 600 mg with V = 30 L If V = 6 L an IV Bolus Dose of 500 mg would result in a Cp 0 of 3.3 mg/l (=500/6) Dosage Calculation Continuous Infusion Cp ss k0 k0 = = kel V Clearance = k0 V area β k0 = Cp ss kel V If V = 5 L and kel = 0.2 hr - a k0 of 90 mg/hr is required to produce a Cp ss of 30 mg/l Chapter 30 4
15 Plasma Concentration Time to Steady State Cp can be calculated after an IV bolus dose from A, B, α and β Cp after an IV infusion somewhat more involved Time to steady state controlled by β value Can be slow with long biological half-life I.V. Bolus and Infusion I.V. Bolus and Infusion kel = 0.2 hr - ; k2 = 2 hr - ; k2 = hr - ; V = 5 L; Bolus = 450 mg; k0 = 90 mg/hr I.V. Bolus and Infusion I.V. Bolus and Infusion kel = 0.2 hr - ; k2 = 2 hr - ; k2 = hr - ; V = 5 L; Bolus = 300 or 600 mg; k0 = 90 mg/hr Chapter 30 5
16 Fast and Slow I.V. Infusion I.V. Infusion - Fast/Slow kel = 0.2 hr-; k2 = 2 hr-; k2 = hr-; V = 5 L; Infusion Rate 300 mg/hr for 4 hr then 90 mg/hr Oral Administration Scheme Drug in GI Tract ka X Central k2 X 2 Peripheral k2 kel Differential Equation dx = ka Xg + k2 X dt 2 ( k2 + kel) X Chapter 30 6
17 Semi-log Plot 0 Oral - Two Compartment with Distribution Phase A = 20 mg/l; B = 5 mg/l; C = -35 mg/l; α = hr - ; β = 0. hr - ; ka = 2 hr Semi-log Plot Oral - Two Compartment without Distribution Phase A = 20 mg/l; B = 5 mg/l; C = -35 mg/l; α =.5 hr - ; β = 0.6 hr - ; ka = hr Oral Dose Two Compartment Model Bioavailability calculations the same as for a one compartment model Use AUC comparison or Use U comparison These method work for any linear system (first order disposition) Method of residuals could be used to calculate α, β, and ka (if sufficiently different) Chapter 30 7
18 Cp Calculations Average Cp of 20 mg/l required with V = 5 L, kel = 0.5 hr -, F = 0.9, and τ = 2 hr F Dose Cp = Clearance τ = F Dose kel V τ = F Dose β V β τ Dose = = 600 mg q2h 0.9 MacKinetics Two compartment Demo Example Data - 0 mg IV Bolus Dose Chapter 30 8
19 Clinical Example Lidocaine - Rapidly attain and maintain effective concentrations (2-6 mg/l) Multiple bolus over 5 or 30 min + infusion Exponentially declining infusion Stepwise, tapering infusion k = min - t /2 = 20 min k2 = min - t /2 = 2 min k2 = min - t /2 = 30 min V = 0.49 L/kg = 34 L (70 kg patient) Evans, Schentag, and Jusko Applied Pharmacokinetics, 3rd ed., Applied Therapeutics, Vancouver, WA 992 Lidocaine - Loading Dose Usual Dose - 50 to 0 mg followed by an infusion of - 4 mg/min Dip in concentration below therapeutic range Increasing the loading dose to mg may cause toxic doses Multiple Loading dose approach Initial 75 mg followed by up to six 50 mg bolus doses to effect Ectopic ventricular beats to less than 5 per minute and no complex ventricular arrhymias Lidocaine - Usual Dose min x Chapter 30 9
20 Usual Dose - Simulation Minutes Multiple Bolus Doses Minutes Non Compartmental Analysis Linear Disposition First order elimination and distribution No assumptions about number of compartments Use t max, Cp max, AUC, AUMC New parameters: AUMC (area under moment curve) MRT (mean residence time) MAT (mean absorption time) Chapter 30 20
21 AUMC Area under the Moment Curve Use trapezoidal rule with t versus Cp t data Last segment from Cp last t last where k is slowest (last) exponential k + Cplast k 2 Non Compartmental Analysis Time Cp Cp t AUC AUMC (hr) (mg/l) (mg.hr/l) (mg.hr/l) (mg.hr 2 /L) Linear System - 0 mg IV Plot of Cp versus t IV Data Chapter 30 2
22 Plot of Cp t versus t IV Data 25 Cp t (mg.hr/l) Parameter Calculations MRT = AUMC AUC = 553 = 8.2 hr 67.4 k = MRT = - = 0.22 hr 8.2 Cl = Dose AUC = 0 =.48 L/hr 67.4 V ss = Cl MRT = =2.2 L Non Compartmental Analysis Time (hr) Cp (mg/l) Cp t (mg.hr/l) AUC (mg.hr/l) Linear System mg PO AUMC (mg.hr 2 /L) Chapter 30 22
23 Plot of Cp versus t PO Data Plot of Cp t versus t PO Data 80 Cp t (mg.hr/l) Parameter Calculations MRT( PO) = AUMC AUC = 36 = 9.08 hr 50 MAT=MRT( PO) MRT( IV) = = 0.88 hr ka = MAT = - =.4 hr 0.88 F = AUC PO Dose IV 50 0 = AUC IV Dose PO = 0.89 Chapter 30 23
24 Objectives To draw schemes and write differential equations for multicompartment models To recognize and use integrated equations to calculate dosage regimens To determine parameter values using the method of residuals To calculate various V values To use the non-compartmental method of parameter estimation Chapter 30 24
The general concept of pharmacokinetics
The general concept of pharmacokinetics Hartmut Derendorf, PhD University of Florida Pharmacokinetics the time course of drug and metabolite concentrations in the body Pharmacokinetics helps to optimize
More informationNonlinear pharmacokinetics
5 Nonlinear pharmacokinetics 5 Introduction 33 5 Capacity-limited metabolism 35 53 Estimation of Michaelis Menten parameters(v max andk m ) 37 55 Time to reach a given fraction of steady state 56 Example:
More informationPHA 4123 First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.
PHA 4123 First Exam Fall 1998 On my honor, I have neither given nor received unauthorized aid in doing this assignment. TYPED KEY Name Question 1. / pts 2. /2 pts 3. / pts 4. / pts. / pts 6. /10 pts 7.
More informationPHAR 7632 Chapter 2 Background Mathematical Material
PHAR 7632 Chapter 2 Background Mathematical Material Student Objectives for this Chapter After completing the material in this chapter each student should:- understand exponents and logarithms, algebraically
More informationMathematical Material. Calculus: Objectives. Calculus. 17 January Calculus
Mathematical Material Calculus Differentiation Integration Laplace Transforms Calculus: Objectives To understand and use differential processes and equations (de s) To understand Laplace transforms and
More informationHomework 1 (PHA 5127)
Homework 1 (PHA 5127) 1. The elimination rate constant of a drug is 1 hr -1 : k e =1 hr -1 A. Half-life: t 1/2 = ln(2)/k e = 0.693/1 hr -1 = 0.693 hr B. C 1 =5ng/ml First-order elimination: k e = (ln(c
More informationNoncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M. Foster., Ph.D. University of Washington October 28, 2010
More informationNoncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M. Foster., Ph.D. University of Washington October 18, 2012
More informationBeka 2 Cpt: Two Compartment Model - Loading Dose And Maintenance Infusion
MEDSCI 719 Pharmacometrics Beka 2 Cpt: Two Compartment Model - Loading Dose And Maintenance Infusion Objective 1. To observe the time course of drug concentration in the central and peripheral compartments
More informationHow Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?
How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence? Philippe Colucci 1,2 ; Jacques Turgeon 1,3 ; and Murray
More informationNon Compartmental Analysis
4/8/22 HAR 7633 Basic harmacokineics haper 2 Non omparmenal Analysis Typical linical ublicaion: Wong SL e al., lin. harmacol. Ther. 73: 34 (23) harmacokineics and pharmacodynamics of abarelix, a gonadoropin
More informationPHAR 7633 Chapter 12 Physical-Chemical Factors Affecting Oral Absorption
PHAR 7633 Chapter 12 Physical-Chemical Factors Affecting Oral Absorption Physical-Chemical Factors Affecting Oral Absorption Student Objectives for this Chapter After completing the material in this chapter
More informationAPPLICATION OF LAPLACE TRANSFORMS TO A PHARMACOKINETIC OPEN TWO-COMPARTMENT BODY MODEL
Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 74 No. 5 pp. 1527ñ1531, 2017 ISSN 0001-6837 Polish Pharmaceutical Society APPLICATION OF LAPLACE TRANSFORMS TO A PHARMACOKINETIC OPEN TWO-COMPARTMENT BODY
More informationDescription of UseCase models in MDL
Description of UseCase models in MDL A set of UseCases (UCs) has been prepared to illustrate how different modelling features can be implemented in the Model Description Language or MDL. These UseCases
More information3 Results. Part I. 3.1 Base/primary model
3 Results Part I 3.1 Base/primary model For the development of the base/primary population model the development dataset (for data details see Table 5 and sections 2.1 and 2.2), which included 1256 serum
More informationIntroduction to PK/PD modelling - with focus on PK and stochastic differential equations
Downloaded from orbit.dtu.dk on: Feb 12, 2018 Introduction to PK/PD modelling - with focus on PK and stochastic differential equations Mortensen, Stig Bousgaard; Jónsdóttir, Anna Helga; Klim, Søren; Madsen,
More informationMIDW 125 Math Review and Equation Sheet
MIDW 125 Math Review and Equation Sheet 1. The Metric System Measures of weight are based on the gram (g): 1 kilogram = 1 kg = 1000 gram = 1000 g = 10 3 g 1 milligram = 1 mg = 10 3 g 1 microgram = 1 g
More informationGoals: To develop skills needed to find the appropriate differential equations to use as mathematical models.
Unit #16 : Differential Equations Goals: To develop skills needed to find the appropriate differential equations to use as mathematical models. Differential Equation Modelling - 1 Differential Equation
More informationUsing ODEs to Model Drug Concentrations within the Field of Pharmacokinetics
Augustana College Augustana Digital Commons Mathematics: Student Scholarship & Creative Works Mathematics Spring 2016 Using ODEs to Model Drug Concentrations within the Field of Pharmacokinetics Andrea
More informationONE-COMPARTMENT KINETICS
British Journal of Anaesthesia 1992; 69: 387-396 REVIEW ARTICLE ONE-COMPARTMENT KINETICS J. NORMAN Pharmacokinetics may appear daunting, especially if the background mathematical development is presented
More informationIVIVC Industry Perspective with Illustrative Examples
IVIVC Industry Perspective with Illustrative Examples Presenter: Rong Li Pfizer Inc., Groton, CT rong.li@pfizer.com 86.686.944 IVIVC definition 1 Definition A predictive mathematical treatment describing
More informationRenal perfusion measurement with Ultrasound Contrast Agents. Emilio Quaia. Department of Radiology University of Trieste
Renal perfusion measurement with Ultrasound Contrast Agents Emilio Quaia Department of Radiology University of Trieste Basics of Ultrasound Contrast Agents 1. Chemicals 2. Physics 3. Pharmacokinetics 4.
More informationTK Solver Case Study: Pharmacokinetics
TK Solver Case Study: Pharmacokinetics The content for this example was provided by Professor Prasad Dhurjati of the University of Delaware. It is used there in the class Applied Mathematics for Chemical
More informationPhysical-Chemistry Factors Affecting Oral Absorption. Objectives. ph - Partition Theory. 27 September Chapter 23 1
Physical-Chemistry Factors Affecting Oral Absorption Objectives Understand the physical-chemical factors that affect oral absorption Understand the ph-partition hypothesis as it applies to drug absorption
More informationImpact of saturable distribution in compartmental PK models: dynamics and practical use
J Pharmacokinet Pharmacon (2017) 44:1 16 DOI 10.1007/s1092-016-9500-2 ORIGINAL PAPER Impact of saturable distribution in compartmental PK models: namics and practical use Lambertus A. Peletier 1 Willem
More informationGoals: To develop skills needed to find the appropriate differential equations to use as mathematical models.
Unit #17 : Differential Equations Goals: To develop skills needed to find the appropriate differential equations to use as mathematical models. Reading: Sections 11.5-11.7. In workingwiththemodels insections11.5
More informationPlot of Laser Operating Current as a Function of Time Laser Test Data
Chapter Repeated Measures Data and Random Parameter Models Repeated Measures Data and Random Parameter Models Chapter Objectives Understand applications of growth curve models to describe the results of
More informationLinear Compartmental Systems-The Basics
Linear Compartmental Systems-The Basics Hal Smith October 3, 26.1 The Model Consider material flowing among n compartments labeled 1, 2,, n. Assume to begin that no material flows into any compartment
More informationPHARMACOKINETIC DERIVATION OF RATES AND ORDERS OF REACTIONS IN MULTI- COMPARTMENT MODEL USING MATLAB
IJPSR (2016), Vol. 7, Issue 11 (Research Article) Received on 29 May, 2016; received in revised form, 07 July, 2016; accepted, 27 July, 2016; published 01 November, 2016 PHARMACOKINETIC DERIVATION OF RATES
More informationCHAPTER 7 SUMMARY AND CONCLUSIONS. constitutes the objective of many a research project in the field of pharmaceutical
CHAPTER 7 SUMMARY AND CONCLUSIONS Taste masking and development of palatable dosage forms of bitter drugs constitutes the objective of many a research project in the field of pharmaceutical technology.
More informationFOUNDATIONS OF PHARMACOKINETICS
FOUNDATIONS OF PHARMACOKINETICS FOUNDATIONS OF PHARMACOKINETICS ALDO RESCIGNO University of Minnesota Minneapolis, Minnesota KLUWER ACADEMIC PUBLISHERS NEW YORK, BOSTON, DORDRECHT, LONDON, MOSCOW ebook
More informationModelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects
Modelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects Thierry Wendling Manchester Pharmacy School Novartis Institutes for
More informationPredicting the Onset of Nonlinear Pharmacokinetics
Citation: CPT Pharmacometrics Syst Pharmacol (208) 7, 670 677; doi:0002/psp4236 ARTICLE Predicting the Onset of Nonlinear Pharmacokinetics Andrew M Stein and Lambertus A Peletier 2 When analyzing the pharmacokinetics
More informationReaction Rate (Kinetics) Reaction Rate
Instructor: Allan Felsot afelsot@tricity.wsu.edu Fall 2 Reaction Rate (Kinetics) ES/RP 3 Fundamentals of Environmental Toxicology Lecture / Pharmacokinetics (Toxicokinetics) & Pharmacodynamics (Toxicodynamics)
More informationPerforming Deconvolution Operations in SAS for Input Rate Computation
ABSTRACT Paper PO11 Performing Deconvolution Operations in SAS for Input Rate Computation Steven Hege, Rho, Inc., Chapel Hill, NC. Deconvolution is a non-parametric technique used in the quantitative analysis
More informationAn effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments
An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments Kayode Ogungbenro and Leon Aarons Centre for Applied Pharmacokinetic Research School of Pharmacy
More informationAP CHEMISTRY CHAPTER 12 KINETICS
AP CHEMISTRY CHAPTER 12 KINETICS Thermodynamics tells us if a reaction can occur. Kinetics tells us how quickly the reaction occurs. Some reactions that are thermodynamically feasible are kinetically so
More informationIDENTIFICATION OF PARAMETERS FOR HILL CURVE USED IN GENERAL ANESTHESIA
IDENTIFICATION OF PARAMETERS FOR HILL CURVE USED IN GENERAL ANESTHESIA Diego F. Sendoya-Losada Department of Electronic Engineering, Faculty of Engineering, Surcolombiana University, Neiva, Huila, Colombia
More informationNonlinear Mixed Effects Models
Nonlinear Mixed Effects Modeling Department of Mathematics Center for Research in Scientific Computation Center for Quantitative Sciences in Biomedicine North Carolina State University July 31, 216 Introduction
More informationModule 39: Periodic Forcing Functions
Module 39: Periodic Forcing Functions For a variety of reasons, periodic functions arise in natural phenomena, either as forcing functions for systems or as states of systems. They arise so often that
More information- 1 - By H. S Steyn, Statistical Consultation Services, North-West University (Potchefstroom Campus)
- 1 - BIOAVAILABILIY AND BIOEQUIVALENCE By H. S Steyn, Statistical Consultation Services, North-West University (Potchefstroom Campus) 1. Bioavailability (see Westlake, 1988) 1.1 Absorption: he aim is
More informationThe Calculus Behind Generic Drug Equivalence
The Calculus Behind Generic Drug Equivalence Stanley R. Huddy and Michael A. Jones Stanley R. Huddy srh@fdu.edu, MRID183534, ORCID -3-33-231) isanassistantprofessorat Fairleigh Dickinson University in
More informationNONLINEAR MODELS IN MULTIVARIATE POPULATION BIOEQUIVALENCE TESTING
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School NONLINEAR MODELS IN MULTIVARIATE POPULATION BIOEQUIVALENCE TESTING Bassam Dahman Virginia Commonwealth University
More informationMODELING THE ABSORPTION, CIRCULATION, AND METABOLISM OF TIRAPAZAMINE
MODELING THE ABSORPTION, CIRCULATION, AND METABOLISM OF TIRAPAZAMINE Olivia Nguyen and Xiaoyu Shi Problem Statement: Tirapazamine (TPZ; 1,2,4-benzotriazin-3-amine 1,4-dioxide) is a hypoxia-activated prodrug
More informationOn approximate solutions in pharmacokinetics
On separation of time scales in pharmacokinetics Piekarski S, Rewekant M. IPPT PAN, WUM Abstract A lot of criticism against the standard formulation of pharmacokinetics has been raised by several authors.
More informationNonparametric Bayes approach for a semimechanistic pharmacodynamic model
University of New Mexico UNM Digital Repository Mathematics & Statistics ETDs Electronic Theses and Dissertations 6-23-2015 Nonparametric Bayes approach for a semimechanistic pharmacokinetic and pharmacodynamic
More informationPET Tracer Kinetic Modeling In Drug
PET Tracer Kinetic Modeling In Drug Discovery Research Applications Sandra M. Sanabria-Bohórquez Imaging Merck & Co., Inc. Positron Emission Tomography - PET PET is an advanced d imaging i technique permitting
More informationOn drug transport after intravenous administration
On drug transport after intravenous administration S.Piekarski (1), M.Rewekant (2) Institute of Fundamental Technological Research Polish Academy of Sciences (1), Medical University of Warsaw, Poland Abstract
More informationValidation of the GastroPlus TM Software Tool and Applications
Validation of the GastroPlus TM Software Tool and Applications Fagen Zhang and Leah Luna The Dow Chemical Company FZ/MB 01.11.11 Acknowledgements Michael Bartels Barun Bhhatarai (Novartis) Tyler Auernhammer
More informationwhere a + b = 2 (this is the general case) These all come from the fact that this is an overall second order reaction.
Chapter 7 Problems Page of 6 //007 7. Hydrolysis of ethyl acetate is as follows: EtAc + OH - Ac - + EtOH. At 5 ºC, the disappearance of OH - is used to determine the extent of the reaction, leading to
More informationMA/ST 810 Mathematical-Statistical Modeling and Analysis of Complex Systems
MA/ST 810 Mathematical-Statistical Modeling and Analysis of Complex Systems Integrating Mathematical and Statistical Models Recap of mathematical models Models and data Statistical models and sources of
More informationTMDD Model Translated from NONMEM (NM- TRAN) to Phoenix NLME (PML)
TMDD Model Translated from NONMEM (NM- TRAN) to Phoenix NLME (PML) Phoenix Modeling Language School March 22, 2018 Loan Pham, Ph.D. Senior Pharmacokinetic Scientist Camargo Pharmaceutical Services 9825
More informationAPPM 1350 Final Exam Fall 2017
APPM 350 Final Exam Fall 207. (26 pts) Evaluate the following. (a) Let g(x) cos 3 (π 2x). Find g (π/3). (b) Let y ( x) x. Find y (4). (c) lim r 0 e /r ln(r) + (a) (9 pt) g (x) 3 cos 2 (π 2x)( sin(π 2x))(
More informationAuthor's personal copy. Mathematical and Computer Modelling
Mathematical and Computer Modelling 50 (2009) 959 974 Contents lists available at ScienceDirect Mathematical and Computer Modelling journal homepage: www.elsevier.com/locate/mcm A mathematical model for
More informationSECTION 9: Kinetics. Chapter 12 in Chang Text
SECTION 9: Kinetics Chapter 12 in Chang Text Outline for Section 9 Part I 9.1. Kinetics in Pharmaceutical Science 9.2. Rates of Reactions 9.3. Reaction Order: Zero-Order, 1 st Order 9.1. Chemical Kinetics
More informationExperiment Flow Analysis
MASSACHUSETTS INSTITUTE OF TECHNOLOGY Department of Physics Physics 8.1X Fall Term 22 Handed out: November 26 Due: Dec 6 at 4 pm Experiment Flow Analysis Problem 1: Here is a summary of the measurements,
More informationANNOUNCEMENTS. HW5 is posted. It is due by 12:00 on 3/11.
ANNOUNCEMENTS HW5 is posted. It is due by 12:00 on 3/11. Two Compartment Model for Drug Distribution from Blood to Peripheral Tissues Drug Injection Plasma/Blood Peripheral Tissues k 1 C 2 k e Mass Balance
More informationEngineering Pharmacology: Pharmacokinetic Models Using Recursive Finite Difference Equations
Engineering Pharmacology: Pharmacokinetic Models Using Recursive Finite Difference Equations GLEN ATLAS Dept of Anesthesiology University of Medicine Dentistry of New Jersey Newark, NJ USA atlasgm@umdnj.edu
More informationNonlinear Elimination of Drugs in One-Compartment Pharmacokinetic Models: Nonstandard Finite Difference Approach for Various Routes of Administration
Matematical and Computational Applications Article Nonlinear Elimination of Drugs in One-Compartment Parmacokinetic Models: Nonstandard Finite Difference Approac for Various Routes of Administration Oluwaseun
More informationEstimation of AUC from 0 to Infinity in Serial Sacrifice Designs
Estimation of AUC from 0 to Infinity in Serial Sacrifice Designs Martin J. Wolfsegger Department of Biostatistics, Baxter AG, Vienna, Austria Thomas Jaki Department of Statistics, University of South Carolina,
More informationNonlinear mixed-effects models using Stata
Nonlinear mixed-effects models using Stata Yulia Marchenko Executive Director of Statistics StataCorp LP 2017 German Stata Users Group meeting Yulia Marchenko (StataCorp) 1 / 48 Outline What is NLMEM?
More informationChapter 14 Chemical Kinetics
Chapter 14 14.1 Factors that Affect Reaction Rates 14.2 Reaction Rates 14.3 Concentration and Rate Laws 14.4 The Change of Concentration with Time 14.5 Temperature and Rate 14.6 Reaction Mechanisms 14.7
More informationChapter 11: CHEMICAL KINETICS
Chapter : CHEMICAL KINETICS Study of the rate of a chemical reaction. Reaction Rate (fast or slow?) Igniting gasoline? Making of oil? Iron rusting? We know about speed (miles/hr). Speed Rate = changes
More informationMarsh Model. Propofol
Marsh Model Propofol This work was supported by FEDER founds through COMPETE-Operational Programme Factors of Competitiveness ( Programa Operacional Factores de Competitividade") and by Portuguese founds
More informationPubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH
PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH From Basic to Translational: INDIRECT BIOASSAYS INDIRECT ASSAYS In indirect assays, the doses of the standard and test preparations are are applied
More informationWeek In Review #8 Covers sections: 5.1, 5.2, 5.3 and 5.4. Things you must know
Week In Review #8 Covers sections: 5.1, 5.2, 5.3 and 5. Things you must know Know how to get an accumulated change by finding an upper or a lower estimate value Know how to approximate a definite integral
More informationUCLA: Math 3B Problem set 8 (solutions) Fall, 2016
This week you will get practice applying the exponential and logistic models and describing their qualitative behaviour. Some of these questions take a bit of thought, they are good practice if you generally
More informationLove and differential equations: An introduction to modeling
Nonlinear Models 1 Love and differential equations: An introduction to modeling November 4, 1999 David M. Allen Professor Emeritus Department of Statistics University of Kentucky Nonlinear Models Introduction
More informationControl 2. Proportional and Integral control
Control 2 Proportional and Integral control 1 Disturbance rejection in Proportional Control Θ i =5 + _ Controller K P =20 Motor K=2.45 Θ o Consider first the case where the motor steadystate gain = 2.45
More informationNumerical Simulations of Stochastic Circulatory Models
Bulletin of Mathematical Biology (1999) 61, 365 377 Article No. bulm.1998.94 Available online at http://www.idealibrary.com on Numerical Simulations of Stochastic Circulatory Models Gejza Wimmer Mathematical
More informationCompartmental Modelling: Eigenvalues, Traps and Nonlinear Models
Compartmental Modelling: Eigenvalues, Traps and Nonlinear Models Neil D. Evans neil.evans@warwick.ac.uk School of Engineering, University of Warwick Systems Pharmacology - Pharmacokinetics Vacation School,
More informationModeling with First-Order Equations
Modeling with First-Order Equations MATH 365 Ordinary Differential Equations J. Robert Buchanan Department of Mathematics Spring 2018 Radioactive Decay Radioactive decay takes place continuously. The number
More informationEstimating terminal half life by non-compartmental methods with some data below the limit of quantification
Paper SP08 Estimating terminal half life by non-compartmental methods with some data below the limit of quantification Jochen Müller-Cohrs, CSL Behring, Marburg, Germany ABSTRACT In pharmacokinetic studies
More informationPHA 5128 Answer CASE STUDY 3 Question #1: Model
PHA 5128 Answr CASE STUDY 3 Spring 2008 Qustion #1: Aminoglycosids hav a triphasic disposition, but tobramycin concntration-tim profil hr is dscribd via a 2-compartmnt modl sinc th alpha phas could not
More informationIntroduction to Pharmacokinetic Modelling Rationale
Introduction to Pharmacokinetic Modelling Rationale Michael Weiss michael.weiss@medizin.uni-halle.de Martin Luther University Halle-Wittenberg Philippus von Hohenheim, known as Paracelsus (1493-1541) Everything
More informationCh 13 Rates of Reaction (Chemical Kinetics)
Ch 13 Rates of Reaction (Chemical Kinetics) Reaction Rates and Kinetics - The reaction rate is how fast reactants are converted to products. - Chemical kinetics is the study of reaction rates. Kinetics
More informationScience One Math. October 23, 2018
Science One Math October 23, 2018 Today A general discussion about mathematical modelling A simple growth model Mathematical Modelling A mathematical model is an attempt to describe a natural phenomenon
More informationDISSOLUTION RATE LIMITING AUC: SIMPLE METHODOLOGY FOR MEASURING DISSOLUTION RATE OF THE ENTIRE DOSE IN BIORELEVANT MEDIA
DISSOLUTION RATE LIMITING AUC: SIMPLE METHODOLOGY FOR MEASURING DISSOLUTION RATE OF THE ENTIRE DOSE IN BIORELEVANT MEDIA Jesse Kuiper and Paul Harmon Outline 2 Understanding the path to absorption (and
More informationA nonlinear feedback model for tolerance and rebound
A nonlinear feedback model for tolerance and rebound Johan Gabrielsson 1 and Lambertus A. Peletier 2 3 Abstract The objectives of the present analysis are to disect a class of turnover feedback models
More informationAssignment 1, SOLUTIONS
MAT 10: Calculus for the Life Sciences I 01.10.2008 Pawel Lorek Assignment 1, SOLUTIONS University of Ottawa Problem 1: [4 points] Suppose that every morning a patient receives the same dose of drug. From
More informationMedicine Concentration in the AutoStart Burette following an Automatic Flow Restart Event
www.analyticamedical.com ANALYTICA LTD ABN 12 006 464 866 Medicine Concentration in the AutoStart Burette following an Automatic Flow Restart Event Geoff Daly, Operations Manager, Analytica Ltd. 29 October
More information9 Nuclear decay Answers to exam practice questions
Pages 173 178 Exam practice questions 1 X-rays are quanta of energy emitted when electrons fall to a lower energy level, and so do not emanate from the nucleus Answer D. 2 Alpha particles, being the most
More informationCTP-656 Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies
Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies 39 th European Cystic Fibrosis Conference 8-11 June 2016, Basel, Switzerland 2014 Concert Pharmaceuticals,
More informationThe Art of Mathematical Modeling
The Art of Mathematical Modeling Lisa Rogers (1) The Art of Mathematical Modeling For these exercises, please also refer to the Algorithm for Constructing a Mathematical Model.
More informationCurrent approaches to covariate modeling
Current approaches to covariate modeling Douglas J. Eleveld, Ph.D., Assistant Professor University of Groningen, University Medical Center Groningen, Department of Anesthesiology, Groningen, The Netherlands
More informationOverview: In this experiment we will study the decay of a radioactive nucleus, Cesium. Figure 1: The Decay Modes of Cesium 137
Radioactivity (Part I and Part II) Objectives: To measure the absorption of beta and gamma rays To understand the concept of half life and to measure the half life of Ba 137* Apparatus: Radioactive source,
More informationMOTION, DISTANCE, AND DISPLACEMENT Q: What is motion? A: Motion is any change in the position or place of an object. is the study of motion (without
MOTION, DISTANCE, AND DISPLACEMENT Q: What is motion? A: Motion is any change in the position or place of an object. is the study of motion (without considering the cause of the motion). Distance vs. Displacement
More information( ) ( = ) = ( ) ( ) ( )
( ) Vρ C st s T t 0 wc Ti s T s Q s (8) K T ( s) Q ( s) + Ti ( s) (0) τs+ τs+ V ρ K and τ wc w T (s)g (s)q (s) + G (s)t(s) i G and G are transfer functions and independent of the inputs, Q and T i. Note
More informationIntroduction to Statistical Population Modeling and Analysis for Pharmacokinetic Data
Introduction to Statistical Population Modeling and Analysis for Pharmacokinetic Data Marie Davidian Department of Statistics, North Carolina State University Raleigh, North Carolina 27695-8203, U.S.A.
More informationMAT 17A - UHP - DISCUSSION #10 December 1, 2015
MAT 17A - UHP - DISCUSSION #10 December 1, 2015 PROBLEM 1. Linear recursion equations Consider the linear recursion (finite difference) equation x j+1 = L x j = a x j + b, x 0 (1), where a and b are: (i)
More informationChallenges in modelling the pharmacokinetics of isoniazid in South African tuberculosis patients
PAGE 2005 Pamplona, Spain Challenges in modelling the pharmacokinetics of isoniazid in South African tuberculosis patients Justin J Wilkins 1, Grant Langdon 1, Helen McIlleron 1, Goonaseelan Pillai 2,
More informationMotion Graphs Refer to the following information for the next four questions.
Motion Graphs Refer to the following information for the next four questions. 1. Match the description provided about the behavior of a cart along a linear track to its best graphical representation. Remember
More informationA Discreet Compartmental Model for Lead Metabolism in the Human Body
A Discreet ompartmental Model for Lead Metabolism in the Human ody Frederika E. Steyn, Stephan V. Joubert and harlotta E. oetzee Tshwane University of Technology Abstract A real-life example of a mathematical
More informationChapter 14 Answers. Practice Examples. 1a. 2a. (a) ; (b) 0.37 M M s
Chapter 14 Answers Practice Examples 1a. 4.46 5 1 1b. 1.6 4 1 a. (a) 3.3 4 1 ; (b) 0.37 M. b..17 M. This value differs from the value of.15 M determined in text Example 14-b because the text used the initial
More information2/18/2019. Position-versus-Time Graphs. Below is a motion diagram, made at 1 frame per minute, of a student walking to school.
Position-versus-Time Graphs Below is a motion diagram, made at 1 frame per minute, of a student walking to school. A motion diagram is one way to represent the student s motion. Another way is to make
More informationPackage clinpk. June 19, 2017
Type Package Title Clinical Pharmacokinetics Toolkit ersion 0.9.0 Date 2017-06-05 Author Ron Keizer Maintainer Ron Keizer Package clinpk June 19, 2017 Calculates equations commonly
More informationTikhonov adaptively regularized gamma variate fitting to assess plasma clearance of inert renal markers
J Pharmacokinet Pharmacodyn (2010) 37:435 474 DOI 10.1007/s10928-010-9167-z Tikhonov adaptively regularized gamma variate fitting to assess plasma clearance of inert renal markers Carl A. Wesolowski Richard
More informationIntegration of SAS and NONMEM for Automation of Population Pharmacokinetic/Pharmacodynamic Modeling on UNIX systems
Integration of SAS and NONMEM for Automation of Population Pharmacokinetic/Pharmacodynamic Modeling on UNIX systems Alan J Xiao, Cognigen Corporation, Buffalo NY Jill B Fiedler-Kelly, Cognigen Corporation,
More informationChapter 30 X Rays GOALS. When you have mastered the material in this chapter, you will be able to:
Chapter 30 X Rays GOALS When you have mastered the material in this chapter, you will be able to: Definitions Define each of the following terms, and use it in an operational definition: hard and soft
More informationChemistry 112 Midterm January 30, 2006
1. (35 points) The reaction of A and B to form products is thought to go according to the following mechanism: A + 2B 2C + D k -1 2C 2C 2C + M k 2 k 3 k 4 G H J + M (a) (5) Identify the products in this
More information